In a proof-of-concept, placebo-controlled trial, the investigational oral selective AKT inhibitor engasertib appeared to be ...

Cefiderocol is as effective as, but not superior to, standard-of-care antibiotics for preventing all-cause mortality in ...

Kimberly Van Der Beek has shared an update as her husband, James Van Der Beek, continues to navigate a stage three cancer ...

Brain implants that deliver electric pulses can ease depression in people who aren't responding to psychiatric drugs, a new ...

Alcohol and tobacco use are two of the most important risk factors for head and neck cancers. However, a large portion of new ...

In 2019, a research group led by Andrés Ozaita, of the Department of Medicine and Life Sciences at Pompeu Fabra University, ...

Research is underway for an experimental treatment for patients with succinate dehydrogenase (SDH) deficient gastrointestinal ...

A phase 2 study reveals high efficacy and manageable safety of venetoclax plus obinutuzumab for untreated CLL/SLL in Japanese ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

Recent polling shows oncologists changing inclination in treatment for mHSPC based on tolerability profiles.

Co-occurring ADHD and substance use create unique challenges. The latest research shows what effective treatment really ...

An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for ...